ETS1 and nonpapillary renal cell carcinoma: The CCK‐8 assay indicated that the increase in the IC50 value of sunitinib after overexpression of the ETS1‐K245R mutant was greater than that after overexpression of ETS1 WT in ccRCC cells (Figure 4O).